Tag: Parasitic disease

With an estimated 350 million people worldwide at risk, leishmaniasis is a serious parasitic disease that can manifest in various forms. The development of effective oral treatments, such as the Impavido treatment (miltefosine), has significantly improved patient care for this often-neglected tropical disease.

Over decades, Metakelfin tablet, a combination antimalarial drug, has played a role in the fight against malaria, a parasitic infection transmitted by mosquitoes. However, due to widespread drug resistance and safety concerns, its use has become highly restricted and is no longer a first-line therapy in most regions. This overview explains its historical function and why newer alternatives are now preferred.